Genetic Mutations and Small Bowel Ulcerating Disease: Role in Diagnosis? [PDF]
Modi R, Storozuk T, Setia N.
europepmc +1 more source
Exploring the Efficacy and Safety of Ketamine for Managing Acute Renal Colic in Emergency Departments: A Systematic Review of Recent Clinical Trials. [PDF]
Sukhram SD +3 more
europepmc +1 more source
Acemetacin-loaded bilosomal gel formulations prepared using different polymers for topical application: Box-Behnken design for bilosomes formulation optimization and in vitro evaluation of the formulations. [PDF]
Demirturk E +5 more
europepmc +1 more source
Case report on anti-GQ1b antibody syndrome: initial symptoms of pupil palsy and periorbital pain. [PDF]
Du Y +6 more
europepmc +1 more source
Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practice. [PDF]
Massmann A +4 more
europepmc +1 more source
Using skin biopsies to measure target occupancy of anti-fibrotic molecules: assay development and application for zampilimab in a primate model of chronic kidney disease and in healthy human volunteers. [PDF]
Huang L +6 more
europepmc +1 more source
Efficacy and safety of combined lumbar plexus and quadratus lumborum block via Shamrock approach at L3 in total hip arthroplasty: a prospective randomized controlled trial. [PDF]
Wang X +6 more
europepmc +1 more source
Sustained-Release Oral Delivery of NSAIDs and Acetaminophen: Advances and Recent Formulation Strategies-A Systematic Review. [PDF]
Drapińska P +3 more
europepmc +1 more source
Related searches:
Formulation and evaluation of proniosomes containing lornoxicam
Drug Delivery and Translational Research, 2016Proniosomes are the new generation provesicular drug delivery system of non-ionic surfactant, lecithin and cholesterol which upon reconstitution get converted into niosomes. The objective of current study was to develop stable and sustain transdermal delivery system for lornoxicam.
Jyotsana R Madan, Kamal Dua
exaly +4 more sources
Effect of the CYP2C9*3 allele on lornoxicam metabolism
Clinica Chimica Acta, 2006We investigated whether the CYP2C9 genotypes would affect lornoxicam metabolism in healthy volunteers.Twelve healthy volunteers who had been genotyped for CYP2C9 gene were selected to participate in our study. After 8 mg lornoxicam was taken, blood samples were drawn from 0 to 36 h.
Zhao-Qian Liu, Yi-Jing He
exaly +3 more sources

